Ask AI
ProCE Banner Activity

Modern S. maltophilia Management: Current Concepts for Best Outcomes

Podcast Episodes

Join Ryan K. Shields, PharmD, MS, in the third of 3 recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. This episode covers the most recent updates on evolving treatment paradigms for S. maltophilia.

Released: November 25, 2025

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with ProCE, LLC  

ProCE Banner

Supporters

Supported by an educational grant from Shionogi Pharma, Inc.

Shionogi Pharma, Inc.

Partners

ProCE, LLC

ProCE Banner

Target Audience

This activity is intended for pulmonology, critical care, and infectious disease specialists, including physicians and clinical pharmacists, who care for critically ill patients with carbapenem-resistant gram-negative infections.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Develop antibiotic management plans for Stenotrophomonas maltophilia infections in critically ill patients

Disclosure

Primary Author

Ryan K. Shields, PharmD, MS: consultant/advisor/speaker: AbbVie, Melinta, Merck, Shionogi; researcher: AbbVie, Innoviva, Melinta, Merck, Roche, Shionogi.